Fujirebio has introduced a groundbreaking blood-based test called the Lumipulse G, which detects two key proteins in the bloodstream to distinguish individuals with Alzheimer’s disease from those with other forms of dementia. This innovative test represents a significant advancement in the field of biotechnology and has the potential to revolutionize the early diagnosis and management of Alzheimer’s disease.
Tags: None
Read more from search.yahoo.com